Personal tools
Sections
You are here: Home Publications 1998
Document Actions

1998

Up one level Last modified February 02, 2007 09:21 AM - EST
This folder holds the following references to publications, sorted by year and author:

Granger, C (1998).
Tirofiban combined with heparin and aspirin prevented ischemic events in patients with unstable angina and non-Q-wave MI
.

Granger, C (1998).
Tirofiban plus aspirin reduced ischemic events in patients with unstable angina
.

Granger, CB (1998).
Heparin management in acute myocardial infarction (AMI)
.

Granger, CB, Becker, R, Tracy, RP, Califf, RM, Topol, EJ, Pieper, KS, Ross, AM, Roth, S, Lambrew, C, and Bovill, EG (1998).
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries
.

Gurbel, PA, Serebruany, VL, Shustov, AR, Bahr, RD, Carpo, C, Ohman, EA, and Topol, EJ (1998).
Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment
.

Gurbel, PA, Serebruany, VL, Shustov, AR, Dalesandro, M, Gumbs, CI, Grablutz, LB, Bahr, RD, Ohman, EM, and Topol, EJ (1998).
Increased baseline levels of platelet P-selectin, and platelet- endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysis
.

Guyton, JR, Goldberg, AC, Kreisberg, RA, Sprecher, DL, Superko, HR, and O'Connor, CM (1998).
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia
.

Harrington, RA (1998).
Platelet inhibition in cardiovascular disease management: aspirin and beyond
.

Harrington, RA, Kleiman, NS, Granger, CB, Ohman, EM, and Berkowitz, SD (1998).
Relation between inhibition of platelet aggregation and clinical outcomes.
.

Hasselblad, V (1998).
Meta-analysis of multitreatment studies
.

Hathaway, WR, Peterson, ED, Wagner, GS, Granger, CB, Zabel, KM, Pieper, KS, Clark, KA, Woodlief, LH, and Califf, RM (1998).
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries
.

Hearne, SE, Davidson, CJ, Zidar, JP, Phillips, HR, Stack, RS, and Sketch, MH (1998).
Internal mammary artery graft angioplasty: acute and long-term outcome
.

Hirsh, J, Warkentin, TE, Raschke, R, Granger, C, Ohman, EM, and Dalen, JE (1998).
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
.

Hochrein, J, Sun, F, Pieper, KS, Lee, KL, Gates, KB, Armstrong, PW, Weaver, WD, Goodman, SG, Topol, EJ, Califf, RM, Granger, CB, and Wagner, GS (1998).
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries
.

Holmvang, L, Hasbak, P, Clemmensen, P, Wagner, G, and Grande, P (1998).
Differences between local investigator and core laboratory interpretation of the admission electrocardiogram in patients with unstable angina pectoris or non-Q-wave myocardial infarction (a Thrombin Inhibition In Myocardial Ischemia [TRIM] substudy)
.

Holmvang, L, Luscher, MS, Clemmensen, P, Thygesen, K, and Grande, P (1998).
Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease (A thrombin inhibition in myocardial ischemia [TRIM] substudy). The TRIM Study Group
.

Iselin-Chaves, IA, Flaishon, R, Sebel, PS, Howell, S, Gan, TJ, Sigl, J, Ginsberg, B, and Glass, PS (1998).
The effect of the interaction of propofol and alfentanil on recall, loss of consciousness, and the Bispectral Index
.

Ismael, MB, Eisenstein, EL, and Hammond, WE (1998).
A comparison of neural network models for the prediction of the cost of care for acute coronary syndrome patients
.

Jaagosild, P, Dawson, NV, Thomas, C, Wenger, NS, Tsevat, J, Knaus, WA, Califf, RM, Goldman, L, Vidaillet, H, and Connors, AF (1998).
Outcomes of acute exacerbation of severe congestive heart failure: quality of life, resource use, and survival. SUPPORT Investigators. The Study to Understand Prognosis and Preferences for Outcomes and Risks of Treatments
.

Johnson, MD, Drew, RH, and Perfect, JR (1998).
Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literature
.

Jollis, JG and Romano, PS (1998).
Pennsylvania's Focus on Heart Attack--grading the scorecard
.

Kereiakes, DJ, Lincoff, AM, Miller, DP, Tcheng, JE, Cabot, CF, Anderson, KM, Weisman, HF, Califf, RM, and Topol, EJ (1998).
Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators
.

Khan, MM, Ellis, SG, Aguirre, FV, Weisman, HF, Wildermann, NM, Califf, RM, Topol, EJ, and Kleiman, NS (1998).
Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications
.

Kleiman, NS, Lincoff, AM, Kereiakes, DJ, Miller, DP, Aguirre, FV, Anderson, KM, Weisman, HF, Califf, RM, and Topol, EJ (1998).
Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators
.

Kleiman, NS, Lincoff, AM, Ohman, EM, and Harrington, RA (1998).
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes - pathophysiologic foundation and clinical findings
.

 

This site conforms to the following standards: